Skip to main content
OpenTrials

Clinical trial condition

Merkel Cell Carcinoma

Explore clinical trials studying Merkel Cell Carcinoma. Study availability and eligibility vary by location and protocol.

68 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Merkel Cell Carcinoma trial results

Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

NCT00346385

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +38 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Nevada Cancer Institute Las Vegas, Nevada, United States
  • The Ohio State University Cancer Center and Research Institute Columbus, Ohio, United States
  • Oklahoma University Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details

Related conditions